The preceding paper in this issue described the synthesis and structural elucidation of the phosphorothioate analogues of 2',5'-oligoadenylate (2-5A) dimer and trimer cores [Karikó, K., Sobol, R. W., Jr., Suhadolnik, L., Li, S. W., Reichenbach, N. L., Suhadolnik, R. J., Charubala, R., & Pfleiderer, W. (1987) Biochemistry (preceding paper in this issue)]. In this report, the binding and activation processes of 2-5A-dependent endoribonuclease (RNase L) have been examined by using four diastereomeric 2',5'-phosphorothioate trimer core analogues and their 5'-monophosphates. These 2',5'-phosphorothioates have revealed a distinct separation of the structural parameters that govern binding vs activation of RNase L. Radiobinding assays have demonstrated that extensive stereochemical modification of the internucleotide linkages of 2-5A is possible without adversely affecting its ability to bind to RNase L. However, a marked difference was observed in the activation of RNase L by the stereochemically modified 2-5A molecules as determined in core--cellulose and rRNA cleavage assays. Three of the four 2',5'-phosphorothioate trimer cores (with RpRp,SpRp, and RpSp internucleotide linkages) are the first 2-5A core molecules able to activate RNase L. For example, the RpRp, SpRp, and RpSp diastereoisomers activate RNase L to hydrolyze poly(U)-3'-[32P]pCp 65%, 20%, and 15%, respectively, at 5 X 10(-5) M. The SpSp diastereomer cannot activate RNase L. The order of RNase L activation was the same for the core analogues and their 5'-monophosphates (RpRp greater than SpRp greater than RpSp).(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Karikó et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: